The human zinc-binding cysteine proteome
- PMID: 39742810
- PMCID: PMC12120685
- DOI: 10.1016/j.cell.2024.11.025
The human zinc-binding cysteine proteome
Abstract
Zinc is an essential micronutrient that regulates a wide range of physiological processes, most often through zinc binding to protein cysteine residues. Despite being critical for modulation of protein function, the cysteine sites in the majority of the human proteome that are subject to zinc binding remain undefined. Here, we develop ZnCPT, a deep and quantitative mapping of the zinc-binding cysteine proteome. We define 6,173 zinc-binding cysteines, uncovering protein families across major domains of biology that are subject to constitutive or inducible zinc binding. ZnCPT enables systematic discovery of zinc-regulated structural, enzymatic, and allosteric functional domains. On this basis, we identify 52 cancer genetic dependencies subject to zinc binding and nominate malignancies sensitive to zinc-induced cytotoxicity. We discover a mechanism of zinc regulation over glutathione reductase (GSR), which drives cell death in GSR-dependent lung cancers. We provide ZnCPT as a resource for understanding mechanisms of zinc regulation of protein function.
Keywords: GSR; cancer; cysteine proteomics; glutathione reductase; zinc; zinc-binding proteome.
Copyright © 2024 The Author(s). Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests E.T.C. is a co-founder, equity holder, and board member of Matchpoint Therapeutics and a co-founder and equity holder in Aevum Therapeutics. J.C. is a co-founder of Matchpoint Therapeutics and consultant for Soltego, Allorion, and Matchpoint Therapeutics and holds equity in Soltego, Allorion, and Matchpoint Therapeutics.
References
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources